Abstract: . . .  Zentralbl Neurochir 65: 191–194, 2004 41. Thomas JA, Crawford DH, Burke M: Clinicopathologic impli- cations of Epstein-Barr virus related B cell lymphoma in im- munocompromised patients. J Clin Pathol 48: 287–290, 1995 42. Tilly H, Rossi A, Stamatoullas A, Lenormand B, Bigorgne C, Kunlin A, et al: Prognostic value of chromosomal abnormalities in follicular lymphoma . Blood 84: 1043–1049, 1994 43. Tomlinson FH, Kurtin PJ, Suman VJ, Scheithauer BW, O’Fallon JR, Kelly PJ, et al: Primary intracerebral malignant lymphoma : a clinicopathological study of 89 patients. J Neurosurg 82: 558–566, 1995 44. Villegas E, Villa S, Lopez-Guillermo A, Petit J, Ribalta T, Graus F: Primary central nervous system lymphoma of T-cell origin: description of two cases and review of the literature. J Neurooncol 34: 157–161, 1997 This work was supported by a National Cancer Institute Research Career Award and a University of California, San Francisco, Brain Tumor SPORE (Specialized Programs of Research Excellence) Award . . .
. . .  Francisco, Brain Tumor SPORE (Specialized Programs of Research Excellence) Award (J.L.R.). Manuscript received September 1, 2006. Accepted in final form October 4, 2006. Address reprint requests to: James L. Rubenstein, M.D, Ph.D., Assistant Professor of Medicine, Division of Hematology/Oncol- ogy, University of California, San Francisco, Room M1282 Box 1270, San Francisco, California 94143. email: jamesr@medicine. ucsf.edu. Neurosurg. Focus / Volume 21 / November, 2006 Pathogenesis of primary CNS lymphoma 5  . . .
. . .  B, Bigorgne C, Kunlin A, et al: Prognostic value of chromosomal abnormalities in follicular lymphoma . Blood 84: 1043–1049, 1994 43. Tomlinson FH, Kurtin PJ, Suman VJ, Scheithauer BW, O’Fallon JR, Kelly PJ, et al: Primary intracerebral malignant lymphoma : a clinicopathological study of 89 patients. J Neurosurg 82: 558–566, 1995 44. Villegas E, Villa S, Lopez-Guillermo A, Petit J, Ribalta T, Graus F: Primary central nervous system lymphoma of T-cell origin: description of two cases and review of the literature. J Neurooncol 34: 157–161, 1997 This work was supported by a National Cancer Institute Research Career Award and a University of California, San Francisco, Brain Tumor SPORE (Specialized Programs of Research Excellence) Award (J.L.R.). Manuscript received September 1, 2006. Accepted in final form October 4, 2006. Address reprint requests to: James L. Rubenstein, M.D, Ph.D., Assistant Professor of Medicine, Division of Hematology/Oncol- ogy, University of California, San Francisco, . . .
--3000,3,500,2744,28672